Skip to main content
ViviCells International, Inc. (VCII)
OTCMKTS · Delayed Price · Currency is USD
0.0000
-0.0001 (-99.00%)
At close: Feb 19, 2026

ViviCells International Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
 TTM FY 1999 FY 1998 FY 1997
Period Ending
 Sep '00 Dec '99 Dec '98 Dec '97
Net Income
--0.01-0.18-0.32
Depreciation & Amortization
-0.030.070.05
Asset Writedown & Restructuring Costs
-0.060.41-
Stock-Based Compensation
-0.050.02-
Other Operating Activities
-0.260.08-0
Change in Accounts Receivable
--1.16-1.66-0.63
Change in Inventory
--0.53-0.55-0.49
Change in Accounts Payable
--0.09-0.140.26
Change in Income Taxes
-0.230.1-
Change in Other Net Operating Assets
--0.040.040.04
Operating Cash Flow
--1.21-1.82-1.08
Capital Expenditures
--0.05-0.03-0.03
Investing Cash Flow
--0.05-0.03-0.03
Long-Term Debt Issued
-1.31.261.08
Long-Term Debt Repaid
--0.06-0.02-0.05
Net Debt Issued (Repaid)
-1.241.241.02
Issuance of Common Stock
-0.090.60.08
Other Financing Activities
--0.05--
Financing Cash Flow
-1.281.841.1
Net Cash Flow
-0.02-0.01-0
Free Cash Flow
--1.26-1.85-1.11
Free Cash Flow Margin
--33.39%-52.46%-61.16%
Cash Interest Paid
-0.040.040.03
Levered Free Cash Flow
--1.42--
Unlevered Free Cash Flow
--1.1--
Change in Working Capital
--1.6-2.22-0.82
Source: S&P Capital IQ. Standard template. Financial Sources.